SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report
SEC Accession No. 0001144204-09-021599
Filing Date
2009-04-21
Accepted
2009-04-21 13:39:22
Documents
2
Period of Report
2009-04-16
Filing Date Changed
2009-04-21
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 v146769_8k.htm 8-K 22951
2 v146769_ex3-1.htm EX-3.1 9425
  Complete submission text file 0001144204-09-021599.txt   34305
Mailing Address MIDDLE SECTION, LONGMAO STREET, AREA A LAIYANG WAIXIANGXING INDUSTRIAL PARK LAIYANG CITY, YANTAI F4 710075
Business Address MIDDLE SECTION, LONGMAO STREET, AREA A LAIYANG WAIXIANGXING INDUSTRIAL PARK LAIYANG CITY, YANTAI F4 710075 5619889880
Genesis Pharmaceuticals Enterprises, Inc. (Filer) CIK: 0001091164 (see all company filings)

IRS No.: 651130026 | State of Incorp.: FL | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 000-53037 | Film No.: 09761214
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1